Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Raffaella M. Schmid"'
Autor:
Katharina A. Domnanich, Cristina Müller, Renata Farkas, Raffaella M. Schmid, Bernard Ponsard, Roger Schibli, Andreas Türler, Nicholas P. van der Meulen
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 1, Iss 1, Pp 1-19 (2016)
Abstract Background Recently, 44Sc (T1/2 = 3.97 h, Eβ+ av = 632 keV, I = 94.3 %) has emerged as an attractive radiometal candidate for PET imaging using DOTA-functionalized biomolecules. The aim of this study was to investigate the potential of usin
Externí odkaz:
https://doaj.org/article/426a2a03dc4a46d2ad31181509126f76
Autor:
Cristina Müller, Patrycja Guzik, Klaudia Siwowska, Susan Cohrs, Raffaella M. Schmid, Roger Schibli
Publikováno v:
Molecules, Vol 23, Iss 6, p 1465 (2018)
Folic-acid-based radioconjugates have been developed for nuclear imaging of folate receptor (FR)-positive tumors; however, high renal uptake was unfavorable in view of a therapeutic application. Previously, it was shown that pre-injection of pemetrex
Externí odkaz:
https://doaj.org/article/40ac09529df748eea1fce3996a0e14e8
Publikováno v:
Pharmaceuticals, Vol 10, Iss 3, p 72 (2017)
The folate receptor (FR) is expressed in a variety of gynecological cancer types. It has been widely used for tumor targeting with folic acid conjugates of diagnostic and therapeutic probes. The cervical KB tumor cells have evolved as the standard mo
Externí odkaz:
https://doaj.org/article/18cc818f27e04e20abf6052df61523ef
Autor:
Klaudia Siwowska, Roger Schibli, Cristina Müller, Simon M. Ametamey, Viola Groehn, Raffaella M. Schmid, Silvan D. Boss
Publikováno v:
The Journal of Nuclear Medicine, 60 (1)
The aim of this study was to develop the radiosyntheses of diastereomerically pure 6R- and 6S-3'-aza-2'-18F-fluoro-5-methyltetrahydrofolate (MTHF) (6R-18F-1 and 6S-18F-1) using the integrated approach and to compare the in vitro and in vivo performan
Autor:
Roger Schibli, Silvan D. Boss, Raffaella M. Schmid, Cristina Müller, Josephine I. Büchel, Klaudia Siwowska, Viola Groehn, Simon M. Ametamey
Publikováno v:
Bioconjugate Chemistry. 29:1119-1130
5-Methyltetrahydrofolate (5-MTHF), a reduced folate form, is the biologically active folate involved in many different metabolic processes. To date, there are no studies available in the literature on 18F-labeled 6S- and 6R-5-MTHF radiotracers for im
Autor:
Silvan D, Boss, Cristina, Müller, Klaudia, Siwowska, Raffaella M, Schmid, Viola, Groehn, Roger, Schibli, Simon M, Ametamey
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 60(1)
The aim of this study was to develop the radiosyntheses of diastereomerically pure 6
Autor:
Silvan D, Boss, Cristina, Müller, Klaudia, Siwowska, Josephine I, Büchel, Raffaella M, Schmid, Viola, Groehn, Roger, Schibli, Simon M, Ametamey
Publikováno v:
Bioconjugate chemistry. 29(4)
5-Methyltetrahydrofolate (5-MTHF), a reduced folate form, is the biologically active folate involved in many different metabolic processes. To date, there are no studies available in the literature on
Autor:
Martina Benešová, Cristina Müller, Roger Schibli, Raffaella M. Schmid, Francesca Borgna, Renata Farkas
Publikováno v:
Bioconjugate Chemistry, 28 (9)
The development of (radio)pharmaceuticals with favorable pharmacokinetic profiles is crucial for allowing the optimization of the imaging or therapeutic potential and the minimization of undesired side effects. The aim of this study was, therefore, t
Autor:
Katharina Anna Domnanich, Nicholas P. van der Meulen, Cristina Müller, Bernard Ponsard, Renata Farkas, Raffaella M. Schmid, Andreas Türler, Roger Schibli
Publikováno v:
Domnanich, Katharina Anna; Müller, Cristina; Farkas, Renata; Schmid, Raffaella M.; Ponsard, Bernard; Schibli, Roger; Türler, Andreas; van der Meulen, Nicholas P. (2016). 44Sc for labeling of DOTA-and NODAGA-functionalized peptides: preclinical in vitro and in vivo investigations. EJNMMI Radiopharmacy and Chemistry, 1(1), p. 8. Springer 10.1186/s41181-016-0013-5
EJNMMI Radiopharmacy and Chemistry, Vol 1, Iss 1, Pp 1-19 (2016)
Ejnmmi Radiopharmacy and Chemistry
EJNMMI Radiopharmacy and Chemistry, Vol 1, Iss 1, Pp 1-19 (2016)
Ejnmmi Radiopharmacy and Chemistry
Background Recently, 44Sc (T1/2 = 3.97 h, Eβ+ av = 632 keV, I = 94.3 %) has emerged as an attractive radiometal candidate for PET imaging using DOTA-functionalized biomolecules. The aim of this study was to investigate the potential of using NODAGA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f44e6afce732d278b4ca4e0d12b16f01
https://boris.unibe.ch/93779/1/art%3A10.1186%2Fs41181-016-0013-5.pdf
https://boris.unibe.ch/93779/1/art%3A10.1186%2Fs41181-016-0013-5.pdf
Autor:
Cristina Müller, Raffaella M. Schmid, Nicholas P. van der Meulen, C. Vermeulen, Karl Johnston, Ulli Köster, Andreas Türler
Publikováno v:
Müller, Cristina; Vermeulen, Christiaan; Johnston, Karl; Köster, Ulli; Schmid, Raffaella; Türler, Andreas; van der Meulen, Nicholas P. (2016). Preclinical in vivo application of 152Tb-DOTANOC: a radiolanthanide for PET imaging. EJNMMI research, 6(1), p. 35. Springer 10.1186/s13550-016-0189-4
EJNMMI Research
'EJNMMI Research ', vol: 6, pages: 35-1-35-10 (2016)
EJNMMI Research
'EJNMMI Research ', vol: 6, pages: 35-1-35-10 (2016)
Background Terbium has attracted the attention of researchers and physicians due to the existence of four medically interesting radionuclides, potentially useful for SPECT and PET imaging, as well as for α- and β−-radionuclide therapy. The aim of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::267f5c3424c5ab0f22ce581438b3d9b4